Loading...
Reach Banner
Keywords
Last name
Institution

Joon Ho Moon

TitleResearch Fellow
InstitutionThe Hospital for Sick Children
DepartmentTranslational Medicine
Address555 University Avenue
Toronto ON M5G 1X8
Phone416-813-1500
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Kim SA, Lee J, Moon JH, Lee H, Jang J, Cheong JW, Youk J, Choi Y, Kang M, Shin M, Koh Y, Shin S. Utility of allogeneic hematopoietic stem cell transplantation using international donors in a homogenous ethnic population: question in the era of various alternative donors. Ann Hematol. 2018 Nov 19. PMID: 30456421.
      View in: PubMed
    2. Lee GW, Park SW, Go SI, Kim HG, Kim MK, Min CK, Kwak JY, Bae SB, Yoon SS, Lee JJ, Kim KH, Nam SH, Mun YC, Kim HJ, Bae SH, Shin HJ, Lee JH, Park JS, Jeong SH, Lee MH, Lee HS, Park KW, Lee WS, Lee SM, Lee JO, Hyun MS, Jo DY, Lim SN, Lee JH, Kim H, Cho DY, Do YR, Kim JA, Park SK, Kim JS, Kim SJ, Yi HG, Moon JH, Choi CW, Kim SH, Kim BS, Park MR, Shim H, Song MK, Kim Y, Kim K. The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma. Acta Haematol. 2018; 140(3):146-156. PMID: 30253397.
      View in: PubMed
    3. Das E, Moon JH, Lee JH, Thakkar N, Pausova Z, Sung HK. Adipose Tissue and Modulation of Hypertension. Curr Hypertens Rep. 2018 Sep 18; 20(11):96. PMID: 30229358.
      View in: PubMed
    4. Yhim HY, Park Y, Han YH, Kim S, Kang SR, Moon JH, Jeong JH, Shin HJ, Kim K, Choi YS, Kim K, Kim MK, Kong E, Kim DS, Eo JS, Lee JH, Kang DY, Lee WS, Lee SM, Do YR, Ham JS, Kim SJ, Kim WS, Choi JY, Yang DH, Kwak JY. Correction to: a risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score. Eur J Nucl Med Mol Imaging. 2018 Sep 17. PMID: 30221329.
      View in: PubMed
    5. Lee YJ, Baek DW, Ahn JS, Ahn SY, Jung SH, Yang DH, Lee JJ, Kim HJ, Ham JY, Suh JS, Sohn SK, Moon JH. Impact of Consolidation Cycles Before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission. Clin Lymphoma Myeloma Leuk. 2018 Dec; 18(12):e529-e535. PMID: 30268640.
      View in: PubMed
    6. Baek DW, Lee YJ, Kim H, Ahn SY, Ahn JS, Shin HJ, Lee WS, Lee SM, Song IC, Lee HS, Park SW, Choi Y, Cho YY, Bae SH, Kim HJ, Sohn SK, Moon JH. Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohorts. Ann Hematol. 2018 Dec; 97(12):2309-2317. PMID: 30073392.
      View in: PubMed
    7. Yhim HY, Park Y, Han YH, Kim S, Kang SR, Moon JH, Jeong JH, Shin HJ, Kim K, Choi YS, Kim K, Kim MK, Kong E, Kim DS, Eo JS, Lee JH, Kang DY, Lee WS, Lee SM, Do YR, Ham JS, Kim SJ, Kim WS, Choi JY, Yang DH, Kwak JY. A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score. Eur J Nucl Med Mol Imaging. 2018 Dec; 45(13):2274-2284. PMID: 30056546.
      View in: PubMed
    8. Park H, Lee YJ, Shin SJ, Lee J, Park S, Kim I, Moon JH, Lee H, Jang JH, Yoon SS, Koh Y. Which donor is better when a matched donor is not available domestically? Comparison of outcomes of allogeneic stem cell transplantation with haploidentical and international donors in a homogenous ethnic population. Leuk Res. 2018 Jun; 69:31-38. PMID: 29649752.
      View in: PubMed
    9. Shin J, Koh Y, Yoon SH, Cho JY, Kim DY, Lee KH, Kim HJ, Ahn JS, Kim YK, Park J, Sohn SK, Moon JH, Lee YJ, Yoon S, Lee JO, Cheong JW, Kim KH, Kim SH, Kim HG, Kim H, Nam SH, Do YR, Park SG, Park SK, Bae SH, Song HH, Shin DY, Oh D, Kim MK, Jung CW, Park S, Kim I. A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKorea. Cancer Med. 2018 May; 7(5):1814-1823. PMID: 29577674.
      View in: PubMed
    10. Jung SH, Lee JJ, Kim JS, Min CK, Kim K, Choi Y, Eom HS, Joo YD, Kim SH, Kwak JY, Kang HJ, Lee JH, Lee HS, Mun YC, Moon JH, Sohn SK, Park SK, Park Y, Shin HJ, Yoon SS. Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150). Biol Blood Marrow Transplant. 2018 May; 24(5):923-929. PMID: 29339269.
      View in: PubMed
    11. Lee JH, Yeganeh A, Konoeda H, Moon JH, Sung HK. Flow Cytometry and Lineage Tracing Study for Identification of Adipocyte Precursor Cell (APC) Populations. Methods Mol Biol. 2018; 1752:111-121. PMID: 29564767.
      View in: PubMed
    12. Sohn SK, Moon JH, Lee IH, Ahn JS, Kim HJ, Chung JS, Shin HJ, Park SW, Lee WS, Lee SM, Kim H, Lee HS, Kim YS, Cho YY, Bae SH, Lee JH, Kim SH, Song IC, Kwon JH, Lee YJ. No benefit of hypomethylating agents compared to supportive care for higher risk myelodysplastic syndrome. Korean J Intern Med. 2018 Nov; 33(6):1194-1202. PMID: 29232940.
      View in: PubMed
    13. Kim KH, Kim YH, Son JE, Lee JH, Kim S, Choe MS, Moon JH, Zhong J, Fu K, Lenglin F, Yoo JA, Bilan PJ, Klip A, Nagy A, Kim JR, Park JG, Hussein SM, Doh KO, Hui CC, Sung HK. Intermittent fasting promotes adipose thermogenesis and metabolic homeostasis via VEGF-mediated alternative activation of macrophage. Cell Res. 2017 Nov; 27(11):1309-1326. PMID: 29039412.
      View in: PubMed
    14. Kim YG, Moon JH, Kim K, Kim H, Kim J, Jeong JS, Lee J, Kang S, Park JS, Kim H. ß-cell serotonin production is associated with female sex, old age, and diabetes-free condition. Biochem Biophys Res Commun. 2017 11 25; 493(3):1197-1203. PMID: 28958940.
      View in: PubMed
    15. Cho H, Yoon DH, Lee JB, Kim SY, Moon JH, Do YR, Lee JH, Park Y, Lee HS, Eom HS, Shin HJ, Min CK, Kim JS, Jo JC, Kang HJ, Mun YC, Lee WS, Lee JJ, Suh C, Kim K. Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy. Am J Hematol. 2017 Dec; 92(12):1280-1286. PMID: 28833417.
      View in: PubMed
    16. Lee H, Kim YR, Kim SJ, Park Y, Eom HS, Oh SY, Kim HJ, Kang HJ, Lee WS, Moon JH, Won YW, Kim TS, Kim JS. Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores. Ann Hematol. 2017 Nov; 96(11):1873-1881. PMID: 28831584.
      View in: PubMed
    17. Choi JK, Cho SY, Yoon SS, Moon JH, Kim SH, Lee JH, Kim JS, Cheong JW, Jang JH, Seo BJ, Kim YJ, Lee HJ, Lee J, Lee JW, Lee DG. Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study. Biol Blood Marrow Transplant. 2017 Oct; 23(10):1773-1779. PMID: 28668492.
      View in: PubMed
    18. Kim MK, Kim K, Min CK, Kwak JY, Bae SB, Yoon SS, Lee JJ, Kim KH, Nam SH, Mun YC, Kim HJ, Bae SH, Shin HJ, Lee JH, Park JS, Jeong SH, Lee MH, Kim YS, Lee HS, Park KW, Lee WS, Lee SM, Lee JO, Hyun MS, Jo DY, Lim SN, Lee JH, Cho DY, Do YR, Kim JA, Park SK, Kim JS, Kim SJ, Kim H, Yi HG, Moon JH, Choi CW, Kim SH, Joo YD, Kim HG, Kim BS, Park MR, Song MK, Kim SY. A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma. Oncotarget. 2017 Jun 06; 8(23):37605-37618. PMID: 28402945.
      View in: PubMed
    19. Poch Martell M, Hamad N, Shin E, Moon JH, Sohn SK, Uhm J, Michelis FV, Viswabandya A, Lipton JH, Messner HA, Kim DDH. Distinctive clinical characteristics and favorable outcomes in patients with large granular lymphocytosis after allo-HCT: 12-year follow-up data. Eur J Haematol. 2017 Aug; 99(2):160-168. PMID: 28449187.
      View in: PubMed
    20. Kim DJ, Lee HS, Moon JH, Sohn SK, Kim HJ, Cheong JW, Jo DY, Kim H, Lee H, Bang SM, Lee WS, Park Y, Lee MH, Lee JH, Bae SH, Kim MK. Can we consider discontinuation of hypomethylating agents in patients with myelodysplastic syndrome : a retrospective study from The Korean Society of Hematology AML/MDS Working Party. Oncotarget. 2017 Oct 03; 8(45):79414-79424. PMID: 29108320.
      View in: PubMed
    21. Moon JH, Roh E, Oh TJ, Kim KM, Moon JH, Lim S, Jang HC, Choi SH. Increased risk of metabolic disorders in healthy young adults with family history of diabetes: from the Korea National Health and Nutrition Survey. Diabetol Metab Syndr. 2017; 9:16. PMID: 28265302.
      View in: PubMed
    22. Moon JH, Hamad N, Sohn SK, Uhm J, Alam N, Gupta V, Lipton JH, Messner HA, Seftel M, Kuruvilla J, Kim DD. Improved prognostic stratification power of CIBMTR risk score with the addition of absolute lymphocyte and eosinophil counts at the onset of chronic GVHD. Ann Hematol. 2017 May; 96(5):805-815. PMID: 28214979.
      View in: PubMed
    23. Ahn JS, Kim HJ, Kim YK, Lee SS, Ahn SY, Jung SH, Yang DH, Lee JJ, Park HJ, Choi SH, Jung CW, Jang JH, Kim HJ, Moon JH, Sohn SK, Won JH, Kim SH, Michael S, Minden MD, Kim DD. 5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia. Oncotarget. 2017 Jan 31; 8(5):8305-8314. PMID: 28039446.
      View in: PubMed
    24. Kim T, Tyndel MS, Kim HJ, Ahn JS, Choi SH, Park HJ, Kim YK, Yang DH, Lee JJ, Jung SH, Kim SY, Min YH, Cheong JW, Sohn SK, Moon JH, Choi M, Lee M, Zhang Z, Kim DDH. The clonal origins of leukemic progression of myelodysplasia. Leukemia. 2017 09; 31(9):1928-1935. PMID: 28090092.
      View in: PubMed
    25. Kwon J, Min CK, Kim K, Han JJ, Moon JH, Kang HJ, Eom HS, Kim MK, Kim HJ, Yoon DH, Lee JO, Lee WS, Lee JH, Lee JJ, Choi YS, Kim SH, Yoon SS. Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study. Cancer Med. 2017 01; 6(1):100-108. PMID: 27905203.
      View in: PubMed
    26. Moon JH, Kim KM, Kim JH, Moon JH, Choi SH, Lim S, Lim JY, Kim KW, Park KS, Jang HC. Predictive Values of the New Sarcopenia Index by the Foundation for the National Institutes of Health Sarcopenia Project for Mortality among Older Korean Adults. PLoS One. 2016; 11(11):e0166344. PMID: 27832145.
      View in: PubMed
    27. Moon JH, Lee BH, Kim JA, Lee YJ, Chae YS, Yhim HY, Kwak JY, Do YR, Park Y, Song MK, Shin HJ, Kim T, Lee JJ, Yang DH. Clinical impact of induction treatment modalities and optimal timing of radiotherapy for the treatment of limited-stage NK/T cell lymphoma. Leuk Res. 2016 10; 49:80-7. PMID: 27608179.
      View in: PubMed
    28. Lee YJ, Park SW, Lee IH, Ahn JS, Kim HJ, Chung JS, Shin HJ, Lee WS, Lee SM, Joo YD, Kim H, Lee HS, Kim YS, Cho YY, Moon JH, Sohn SK. Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromes. Ann Hematol. 2016 Oct; 95(11):1795-804. PMID: 27530461.
      View in: PubMed
    29. Cho NH, Ahn CH, Moon JH, Kwak SH, Choi SH, Lim S, Park KS, Metzger BE, Jang HC. Metabolic syndrome independently predicts future diabetes in women with a history of gestational diabetes mellitus. Medicine (Baltimore). 2016 Aug; 95(35):e4582. PMID: 27583868; PMCID: PMC5008552.
    30. Sohn SK, Moon JH, Lee YJ, Park SW, Kim JY. Survey of experts on therapeutic policies and proposals for the optimal timing for allogeneic peripheral blood stem cell transplantation in transfusion-dependent patients with myelodysplastic syndrome-refractory anemia. Blood Res. 2016 Mar; 51(1):44-9. PMID: 27104191; PMCID: PMC4828528.
    31. Zheng Q, Cao J, Hamad N, Kim HJ, Moon JH, Sohn SK, Jung CW, Lipton JH, Kim DD. Single nucleotide polymorphisms in apoptosis pathway are associated with response to imatinib therapy in chronic myeloid leukemia. J Transl Med. 2016 Mar 24; 14:82. PMID: 27009330; PMCID: PMC4806489.
    32. Lee JH, Kim YA, Moon JH, Min SH, Song YS, Choi SH. Expressive aphasia as the manifestation of hyperglycemic crisis in type 2 diabetes. Korean J Intern Med. 2016 Nov; 31(6):1187-1190. PMID: 26968185.
      View in: PubMed
    33. Yoon JS, Lee YJ, Baek DW, Park HY, Park BE, Moon JH, Sohn SK. New synergistic efficacy of combination of romiplostim and steroid in refractory immune thrombocytopenia patients. Korean J Intern Med. 2018 03; 33(2):435-437. PMID: 26947025.
      View in: PubMed
    34. Kim JS, Yoon DH, Park S, Yoon SS, Cho SG, Min CK, Lee JJ, Yang DH, Kwak JY, Eom HS, Kim WS, Kim H, Do YR, Moon JH, Lee J, Suh C. Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective study. Ann Hematol. 2016 Mar; 95(4):603-11. PMID: 26754633.
      View in: PubMed
    35. Seo SK, Kim KY, Han SA, Yoon JS, Shin SY, Sohn SK, Moon JH. First Korean case of Emberger syndrome (primary lymphedema with myelodysplasia) with a novel GATA2 gene mutation. Korean J Intern Med. 2016 Jan; 31(1):188-90. PMID: 26767875; PMCID: PMC4712426.
    36. Ahn JS, Kim JY, Kim HJ, Kim YK, Lee SS, Jung SH, Yang DH, Lee JJ, Kim NY, Choi SH, Minden MD, Jung CW, Jang JH, Kim HJ, Moon JH, Sohn SK, Won JH, Kim SH, Kim DD. Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant. Ann Hematol. 2016 Jan; 95(2):301-10. PMID: 26537612.
      View in: PubMed
    37. Lim SN, Joo YD, Lee KH, Kim DY, Lee JH, Lee JH, Chi HS, Yun SC, Lee WS, Lee SM, Park S, Kim I, Sohn SK, Moon JH, Ryoo HM, Bae SH, Hyun MS, Kim MK, Kim HJ, Yang DH, Eom HS, Lee GW, Jung CW, Won JH, Kim H, Lee JH, Shin HJ, Jang DY. Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Am J Hematol. 2015 Nov; 90(11):1013-20. PMID: 26228525.
      View in: PubMed
    38. Moon JH, Kwak SH, Jung HS, Choi SH, Lim S, Cho YM, Park KS, Jang HC, Cho NH. Weight Gain and Progression to Type 2 Diabetes in Women With a History of Gestational Diabetes Mellitus. J Clin Endocrinol Metab. 2015 Sep; 100(9):3548-55. PMID: 26171796.
      View in: PubMed
    39. Kim DY, Joo YD, Lim SN, Kim SD, Lee JH, Lee JH, Kim DH, Kim K, Jung CW, Kim I, Yoon SS, Park S, Ahn JS, Yang DH, Lee JJ, Lee HS, Kim YS, Mun YC, Kim H, Park JH, Moon JH, Sohn SK, Lee SM, Lee WS, Kim KH, Won JH, Hyun MS, Park J, Lee JH, Shin HJ, Chung JS, Lee H, Eom HS, Lee GW, Cho YU, Jang S, Park CJ, Chi HS, Lee KH. Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia. Blood. 2015 Aug 06; 126(6):746-56. PMID: 26065651.
      View in: PubMed
    40. Yhim HY, Kim JS, Mun YC, Moon JH, Chae YS, Park Y, Jo JC, Kim SJ, Yoon DH, Cheong JW, Kwak JY, Lee JJ, Kim WS, Suh C, Yang DH. Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma. Biol Blood Marrow Transplant. 2015 Sep; 21(9):1597-604. PMID: 25963920.
      View in: PubMed
    41. Sohn SK, Moon JH. Survey of expert opinions and related recommendations regarding bridging therapy using hypomethylating agents followed by allogeneic transplantation for high-risk MDS. Crit Rev Oncol Hematol. 2015 Aug; 95(2):243-50. PMID: 25840907.
      View in: PubMed
    42. Kim IH, Moon JH, Lim SN, Sohn SK, Kim HG, Lee GW, Kim YS, Lee HS, Kwon KY, Kim SH, Park KT, Chung JS, Lee WS, Lee SM, Hyun MS, Kim H, Ryoo HM, Bae SH, Joo YD. Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overload. Transfusion. 2015 Jul; 55(7):1613-20. PMID: 25764017.
      View in: PubMed
    43. Koo OJ, Ha SK, Park SJ, Park HJ, Kim SJ, Kwon D, Kang JT, Moon JH, Park EJ, Jang G, Lee BC. Intrapancreatic ectopic splenic tissue found in a cloned miniature pig. J Vet Sci. 2015; 16(2):241-4. PMID: 25643801; PMCID: PMC4483510.
    44. Sohn SK, Moon JH. Favorable effects of low-dose anti-thymocyte globulin in a partially-mismatched HLA group in an unrelated allogeneic stem cell transplantation setting. Ann Transplant. 2015 Jan 07; 20:7-15. PMID: 25564881.
      View in: PubMed
    45. Hwang KL, Song MK, Shin HJ, Na HJ, Shin DH, Kim JK, Moon JH, Ahn JS, Song IC, Hong J, Lee GW, Chung JS. Monosomal and complex karyotypes as prognostic parameters in patients with International Prognostic Scoring System higher risk myelodysplastic syndrome treated with azacitidine. Blood Res. 2014 Dec; 49(4):234-40. PMID: 25548756; PMCID: PMC4278004.
    46. Moon JH, Lee YJ, Seo SK, Han SA, Yoon JS, Ham JY, Suh JS, Sohn SK. Outcomes of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients with monosomal karyotypes. Acta Haematol. 2015; 133(4):327-35. PMID: 25503503.
      View in: PubMed
    47. Jeong SH, Moon JH, Kim JS, Yang DH, Park Y, Cho SG, Kwak JY, Eom HS, Won JH, Hong JS, Oh SY, Lee HS, Kim SJ. Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation. Ann Hematol. 2015 Apr; 94(4):617-25. PMID: 25465233.
      View in: PubMed
    48. Shin HC, Seo J, Kang BW, Moon JH, Chae YS, Lee SJ, Lee YJ, Han S, Seo SK, Kim JG, Sohn SK, Park TI. Clinical significance of nuclear factor ?B and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy. Korean J Intern Med. 2014 Nov; 29(6):785-92. PMID: 25378977; PMCID: PMC4219968.
    49. Kim SJ, Koo OJ, Park HJ, Moon JH, da Torre BR, Javaregowda PK, Kang JT, Park SJ, Saadeldin IM, Choi JY, Lee BC, Jang G. Oct4 overexpression facilitates proliferation of porcine fibroblasts and development of cloned embryos. Zygote. 2015 Oct; 23(5):704-11. PMID: 25181424.
      View in: PubMed
    50. Ahn JS, Yang DH, Jung SH, Lee JJ, Kim I, Park S, Chung JS, Shin HJ, Kim DY, Lee KH, Moon JH, Sohn SK, Song IC, Jo DY, Joo YD. Clinical efficacy of mitoxantrone and Ara-C with or without etoposide salvage chemotherapy in adult patients with relapsed or refractory acute lymphoblastic leukemia: retrospective multicenter study of the Korean Adult ALL Working Party. Acta Haematol. 2015; 133(1):91-7. PMID: 25171064.
      View in: PubMed
    51. Kang BW, Sohn SK, Moon JH, Chae YS, Kim JG, Lee SJ, Kim WS, Lee JJ, Lee SR, Park KU, Lee HS, Lee WS, Won JH, Park MR, Kwak JY, Kim MK, Kim HJ, Oh SY, Kang HJ, Suh C. Clinical features and treatment outcomes in patients with mantle cell lymphoma in Korea: Study by the Consortium for Improving Survival of Lymphoma. Blood Res. 2014 Mar; 49(1):15-21. PMID: 24724062; PMCID: PMC3974951.
    52. Koo OJ, Park SJ, Lee C, Kang JT, Kim S, Moon JH, Choi JY, Kim H, Jang G, Kim JS, Kim S, Lee BC. Production of Mutated Porcine Embryos Using Zinc Finger Nucleases and a Reporter-based Cell Enrichment System. Asian-Australas J Anim Sci. 2014 Mar; 27(3):324-9. PMID: 25049958; PMCID: PMC4093273.
    53. Moon JH, Sohn SK, Lambie A, Ellis L, Hamad N, Uhm J, Gupta V, Lipton JH, Messner HA, Kuruvilla J, Kim D. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival. Biol Blood Marrow Transplant. 2014 Apr; 20(4):556-63. PMID: 24447907.
      View in: PubMed
    54. Inamoto Y, Kim DD, Storer BE, Moon JH, Lipton JH, Kuruvilla J, Martin PJ, Flowers ME. Application of CIBMTR risk score to NIH chronic GVHD at individual centers. Blood. 2014 Jan 16; 123(3):453-5. PMID: 24435000; PMCID: PMC3894498.
    55. Sohn SK, Moon JH. Adoptable strategic approaches to improve outcomes of allogeneic peripheral blood stem cell transplantations from unrelated donors. Transfusion. 2014 Jun; 54(6):1673-80. PMID: 24261633.
      View in: PubMed
    56. Song MK, Chung JS, Lee JJ, Jeong SY, Lee SM, Hong JS, Chong A, Moon JH, Kim JH, Lee SM, Kim SJ, Shin HJ. Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma. Cancer Sci. 2013 Dec; 104(12):1656-61. PMID: 24033666.
      View in: PubMed
    57. Kim S, Moon JH, Shin Y, Kim GH, Seo DS. Life comparative analysis of energy consumption and CO2 emissions of different building structural frame types. ScientificWorldJournal. 2013; 2013:175702. PMID: 24227998; PMCID: PMC3817659.
    58. Kim K, Kim SJ, Voelter V, Suh C, Yoon SS, Lee JJ, Kwak JY, Ryoo HM, Kim YS, Moon JH, Park SK, Kim SH, Mun YC, Kim JS, Eom HS, Jo DY, Jun HJ, Kim KH, Lee JO, Lee JH, Min CK. Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea-experience from 110 patients. Ann Hematol. 2014 Jan; 93(1):113-21. PMID: 24026427.
      View in: PubMed
    59. Sohn SK, Moon JH. When is the optimal timing for allogeneic transplantation in the case of MDS patients treated with hypomethylating agents? Expert Rev Hematol. 2013 Aug; 6(4):389-95. PMID: 23991925.
      View in: PubMed
    60. Lee HS, Park LC, Lee EM, Shin SH, Kim YS, Moon JH, Lee WS, Shin HJ, Kim MH, Ye BJ, Chung JS. Predictive factors for rapid neutrophil and platelet engraftment after allogenic peripheral blood stem cell transplantation in patients with acute leukemia. Ann Hematol. 2013 Dec; 92(12):1685-93. PMID: 23896629.
      View in: PubMed
    61. Kang BW, Moon JH, Chae YS, Lee SJ, Kim JG, Kim YK, Lee JJ, Yang DH, Kim HJ, Kim JY, Do YR, Park KU, Song HS, Kwon KY, Kim MK, Lee KH, Hyun MS, Ryoo HM, Bae SH, Kim H, Sohn SK. Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement. Cancer Res Treat. 2013 Jun; 45(2):112-7. PMID: 23864844; PMCID: PMC3710960.
    62. Lee YJ, Moon JH, Shin HC, Seo JW, Han SA, Seo SK, Sohn SK. Two CML patients who subsequently developed features of essential thrombocythemia with JAK2-V617F mutation while in complete cytogenetic remission after treatment with imatinib mesylate. Int J Hematol. 2013 Jun; 97(6):804-7. PMID: 23613267.
      View in: PubMed
    63. Lee SM, Lee WS, Shin HJ, Lee JJ, Sohn SK, Moon JH, Eom HS, Won JH, Lee KH, Lee JH, Kim DY, Yoon SS, Kim I, Jung CW, Kim SJ, Kim H, Lee JH, Ryoo HM, Lee GW, Kim SH, Mun YC, Kim MK, Joo YD. Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia. Ann Hematol. 2013 Aug; 92(8):1101-10. PMID: 23558905.
      View in: PubMed
    64. Song MK, Chung JS, Shin HJ, Moon JH, Ahn JS, Lee HS, Lee SM, Lee GW, Kim SJ, Lee SM. Clinical value of metabolic tumor volume by PET/CT in extranodal natural killer/T cell lymphoma. Leuk Res. 2013 Jan; 37(1):58-63. PMID: 23040533.
      View in: PubMed
    65. Park SJ, Park HJ, Koo OJ, Choi WJ, Moon JH, Kwon DK, Kang JT, Kim S, Choi JY, Jang G, Lee BC. Oxamflatin improves developmental competence of porcine somatic cell nuclear transfer embryos. Cell Reprogram. 2012 Oct; 14(5):398-406. PMID: 23013534.
      View in: PubMed
    66. Huh J, Jung CW, Kim HJ, Kim YK, Moon JH, Sohn SK, Kim HJ, Min WS, Kim DH. Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on disease category. Genes Chromosomes Cancer. 2013 Jan; 52(1):44-55. PMID: 23023762.
      View in: PubMed
    67. Kim HJ, Ahn HK, Jung CW, Moon JH, Park CH, Lee KO, Kim SH, Kim YK, Kim HJ, Sohn SK, Kim SH, Lee WS, Kim KH, Mun YC, Kim H, Park J, Min WS, Kim HJ, Kim DH. KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement. Ann Hematol. 2013 Jan; 92(2):163-71. PMID: 23053179.
      View in: PubMed
    68. Huh J, Kim HJ, Jung CW, Kim HJ, Kim SH, Kim YK, Kim HJ, Shin MG, Moon JH, Sohn SK, Kim SH, Lee WS, Won JH, Mun YC, Kim H, Park J, Min WS, Kim DH. A genome-wide single-nucleotide polymorphism-array can improve the prognostic stratification of the core binding factor acute myeloid leukemia. Am J Hematol. 2012 Oct; 87(10):961-8. PMID: 22886749.
      View in: PubMed
    69. Kong JH, Mun YC, Kim S, Choi HS, Kim YK, Kim HJ, Moon JH, Sohn SK, Kim SH, Jung CW, Dennis Kim DH. Polymorphisms of ERCC1 genotype associated with response to imatinib therapy in chronic phase chronic myeloid leukemia. Int J Hematol. 2012 Sep; 96(3):327-33. PMID: 22821389.
      View in: PubMed
    70. Chae YS, Shin H, Sohn SK, Lee SJ, Moon JH, Kang BW, Kim JG, Yang DH, Lee JJ, Park TI. Absolute lymphocyte count at day + 21 predicts survival in patients with early-stage diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, adriamycin, vincristine and prednisone. Leuk Lymphoma. 2012 Sep; 53(9):1757-63. PMID: 22372848.
      View in: PubMed
    71. Choi JY, Kim JG, Lee YJ, Chae YS, Sohn SK, Moon JH, Kang BW, Jung MK, Jeon SW, Park JS, Choi GS. Prognostic Impact of Polymorphisms in the CASPASE Genes on Survival of Patients with Colorectal Cancer. Cancer Res Treat. 2012 Mar; 44(1):32-6. PMID: 22500158; PMCID: PMC3322198.
    72. Kim SJ, Moon JH, Kim H, Kim JS, Hwang YY, Intragumtornchai T, Issaragrisil S, Kwak JY, Lee JJ, Won JH, Reksodiputro AH, Lim ST, Cheng AL, Kim WS, Kwong YL. Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group. Leuk Lymphoma. 2012 Aug; 53(8):1515-24. PMID: 22273250.
      View in: PubMed
    73. Shin HC, Lee YJ, Moon JH, Lee SJ, Kang BW, Chae YS, Kim JG, Choi JY, Seo JW, Kim YK, Suh JS, Sohn SK. Feasibility of non-TBI conditioning with busulfan and fludarabine for allogeneic stem cell transplantation in lymphoid malignancy. Korean J Intern Med. 2012 Mar; 27(1):72-83. PMID: 22403503; PMCID: PMC3295992.
    74. Song MK, Chung JS, Shin HJ, Moon JH, Lee JJ, Yoon SS, Kim JS, Lee JO, Do YR, Lee HS, Park EK. Cyclophosphamide-containing regimen (TCD) is superior to melphalan-containing regimen (MPT) in elderly multiple myeloma patients with renal impairment. Ann Hematol. 2012 Jun; 91(6):889-96. PMID: 22237937.
      View in: PubMed
    75. Lee SJ, Kang BW, Moon JH, Chae YS, Kim JG, Jung JS, Cho GJ, Jo DY, Kim YK, Kim HJ, Ryoo HM, Eom HS, Lee SM, Le SM, Joo YD, Won JH, Park MR, Kim MK, Hyun MS, Sohn SK. Comparable analysis of outcomes for allogeneic peripheral blood stem cell transplantation from matched related and matched unrelated donors in acute myeloid leukemia. Acta Haematol. 2012; 127(2):81-9. PMID: 22143083.
      View in: PubMed
    76. Yi JH, Huh J, Kim HJ, Kim SH, Kim HJ, Kim YK, Sohn SK, Moon JH, Kim SH, Kim KH, Won JH, Mun YC, Kim H, Park J, Jung CW, Kim DH. Adverse prognostic impact of abnormal lesions detected by genome-wide single nucleotide polymorphism array-based karyotyping analysis in acute myeloid leukemia with normal karyotype. J Clin Oncol. 2011 Dec 10; 29(35):4702-8. PMID: 22084373.
      View in: PubMed
    77. Cho YY, Kim JG, Chae YS, Sohn SK, Kang BW, Moon JH, Jeon SW, Park JS, Park JY, Choi GS. No Association of Insulin-like Growth Factor Gene Polymorphisms with Survival in Patients with Colorectal Cancer. Cancer Res Treat. 2011 Sep; 43(3):189-94. PMID: 22022297; PMCID: PMC3192881.
    78. Moon JH, Lee SJ, Lee YJ, Kang BW, Chae YS, Kim JG, Suh JS, Sohn SK. Pilot study on combination of azacitidine and low-dose cytarabine for patients with refractory anemia with excess blast. Ann Hematol. 2012 Mar; 91(3):367-73. PMID: 21947085.
      View in: PubMed
    79. Lee YJ, Moon JH, Kim JG, Chae YS, Kang BW, Lee SJ, Choi JY, Shin HC, Seo JW, Sohn SK. Prospective Randomization Trial of G-CSF-Primed Induction Regimen versus Standard Regimen in Patients with AML. Chonnam Med J. 2011 Aug; 47(2):80-4. PMID: 22111065; PMCID: PMC3214872.
    80. Kang BW, Kim JG, Chae YS, Lee YJ, Lee SJ, Moon JH, Sohn SK, Jung MK, Jeon SW, Jang YJ, Seo J, Lee YH, Kwon O, Chung HY, Yu W. Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancer. Invest New Drugs. 2012 Aug; 30(4):1671-5. PMID: 21845514.
      View in: PubMed
    81. Kim DH, Lee ST, Won HH, Kim S, Kim MJ, Kim HJ, Kim SH, Kim JW, Kim HJ, Kim YK, Sohn SK, Moon JH, Jung CW, Lipton JH. A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia. Blood. 2011 Jun 23; 117(25):6906-11. PMID: 21540461.
      View in: PubMed
    82. Moon JH, Sohn SK, Kim SN, Park SY, Yoon SS, Kim IH, Kim HJ, Kim YK, Min YH, Cheong JW, Kim JS, Jung CW, Kim DH. Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients. Med Oncol. 2012 Jun; 29(2):1179-85. PMID: 21472487.
      View in: PubMed
    83. Kim JG, Chae YS, Sohn SK, Kang BW, Moon JH, Lee SJ, Jeon SW, Park JS, Park JY, Choi GS. Clinical significance of genetic variations in the PI3K/PTEN/AKT/mTOR pathway in Korean patients with colorectal cancer. Oncology. 2010; 79(3-4):278-82. PMID: 21412012.
      View in: PubMed
    84. Huh J, Jung CW, Kim JW, Kim HJ, Kim SH, Shin MG, Kim YK, Kim HJ, Suh JS, Moon JH, Sohn SK, Nam GH, Lee JE, Kim DH. Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der(9) deletion, but does not predict treatment outcomes after imatinib therapy in chronic myeloid leukemia. Ann Hematol. 2011 Nov; 90(11):1255-64. PMID: 21384125.
      View in: PubMed
    85. Kang BW, Kim JG, Lee SJ, Chae YS, Moon JH, Sohn SK, Jeon SW, Jung MK, Lim KH, Jang YS, Park JS, Jun SH, Choi GS. Clinical significance of microsatellite instability for stage II or III colorectal cancer following adjuvant therapy with doxifluridine. Med Oncol. 2011 Dec; 28 Suppl 1:S214-8. PMID: 20953739.
      View in: PubMed
    86. Kim YJ, Lee SJ, Kim JG, Sohn SK, Chae YS, Moon JH, Kang BW, Park JY, Park JS, Choi GS. No association of the eNOS gene polymorphisms with survival in patients with colorectal cancer. Med Oncol. 2011 Dec; 28(4):1075-9. PMID: 20706876.
      View in: PubMed
    87. Lee SJ, Kim JG, Sohn SK, Chae YS, Moon JH, Kang BW, Park JS, Park JY, Choi GS. No association of the hypoxia-inducible factor-1a gene polymorphisms with survival in patients with colorectal cancer. Med Oncol. 2011 Dec; 28(4):1032-7. PMID: 20635169.
      View in: PubMed
    88. Chae YS, Kim JG, Sohn SK, Lee SJ, Kang BW, Moon JH, Park JY, Jeon SW, Bae HI, Choi GS, Jun SH. RIPK1 and CASP7 polymorphism as prognostic markers for survival in patients with colorectal cancer after complete resection. J Cancer Res Clin Oncol. 2011 Apr; 137(4):705-13. PMID: 20567846.
      View in: PubMed
    89. Chae YS, Lee SJ, Moon JH, Kang BW, Kim JG, Sohn SK, Jung JH, Park HY, Park JY, Kim HJ, Lee SW. VARS2 V552V variant as prognostic marker in patients with early breast cancer. Med Oncol. 2011 Dec; 28(4):1273-80. PMID: 20503108.
      View in: PubMed
    90. Kang BW, Moon JH, Chae YS, Kim JG, Kim SN, Sohn SK. Pre-emptive treatment with nilotinib after second allogeneic transplantation in a Philadelphia chromosome-positive acute lymphoblastic leukemia patient with high risk of relapse. Acta Haematol. 2010; 123(4):242-7. PMID: 20460883.
      View in: PubMed
    91. Moon JH, Kim SN, Kang BW, Chae YS, Kim JG, Baek JH, Park JH, Song MK, Chung JS, Won JH, Lee SM, Joo YD, Kim YK, Kim HJ, Jo DY, Sohn SK. Predictive value of pretreatment risk group and baseline LDH levels in MDS patients receiving azacitidine treatment. Ann Hematol. 2010 Jul; 89(7):681-9. PMID: 20237926.
      View in: PubMed
    92. Kang BW, Moon JH, Chae YS, Kim JG, Jung JS, Cho GJ, Jo DY, Kim YK, Kim HJ, Ryoo HM, Eom HS, Lee SM, Joo YD, Won JH, Park MR, Kim MK, Hyun MS, Sohn SK. Comparative analysis of outcomes of allogeneic peripheral blood stem cell transplantation from related and unrelated donors. Ann Hematol. 2010 Aug; 89(8):813-20. PMID: 20177897.
      View in: PubMed
    93. Yang DH, Kim YK, Sohn SK, Chung JS, Joo YD, Lee JH, Lee JL, Ahn JS, Moon JH, Shin HJ, Choi YJ, Lee WS, Kim HJ, Lee JJ. Induction treatment with cyclophosphamide, thalidomide, and dexamethasone in newly diagnosed multiple myeloma: a phase II study. Clin Lymphoma Myeloma Leuk. 2010 Feb; 10(1):62-7. PMID: 20223731.
      View in: PubMed
    94. Park JH, Kim NS, Park JY, Chae YS, Kim JG, Sohn SK, Moon JH, Kang BW, Ryoo HM, Bae SH, Choi GS, Jun SH. MGMT -535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy. J Cancer Res Clin Oncol. 2010 Aug; 136(8):1135-42. PMID: 20091185.
      View in: PubMed
    95. Lee HC, Kim JG, Chae YS, Sohn SK, Kang BW, Moon JH, Jeon SW, Lee MH, Lim KH, Park JY, Choi GS, Jun SH. Prognostic impact of microRNA-related gene polymorphisms on survival of patients with colorectal cancer. J Cancer Res Clin Oncol. 2010 Jul; 136(7):1073-8. PMID: 20044760.
      View in: PubMed
    96. Lee SJ, Kim JG, Sohn SK, Chae YS, Moon JH, Kim SN, Bae HI, Chung HY, Yu W. No association of vascular endothelial growth factor-A (VEGF-A) and VEGF-C expression with survival in patients with gastric cancer. Cancer Res Treat. 2009 Dec; 41(4):218-23. PMID: 20057967; PMCID: PMC2802841.
    97. Kim YK, Sohn SK, Lee JH, Yang DH, Moon JH, Ahn JS, Kim HJ, Lee JJ. Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study. Ann Hematol. 2010 May; 89(5):475-82. PMID: 19921192.
      View in: PubMed
    98. Jung JH, Chae YS, Moon JH, Kang BW, Kim JG, Sohn SK, Park JY, Lee MH, Park HY. TNF superfamily gene polymorphism as prognostic factor in early breast cancer. J Cancer Res Clin Oncol. 2010 May; 136(5):685-94. PMID: 19890662.
      View in: PubMed
    99. Kang BW, Lee SJ, Moon JH, Kim SN, Chae YS, Kim JG, Hwang YJ, Sohn SK. Chronic myeloid leukemia patient manifesting fatal hepatitis B virus reactivation during treatment with imatinib rescued by liver transplantation: case report and literature review. Int J Hematol. 2009 Oct; 90(3):383-387. PMID: 19641858.
      View in: PubMed
    100. Moon JH, Lee SJ, Kim JG, Chae YS, Kim SN, Kang BW, Suh JS, Lee KS, Sohn SK. Clinical significance of autoantibody expression in allogeneic stem-cell recipients. Transplantation. 2009 Jul 27; 88(2):242-50. PMID: 19623021.
      View in: PubMed
    101. Chae YS, Kim JG, Sohn SK, Moon JH, Kim SN, Lee SJ, Park TI, Lee MH. Lymphotoxin alfa and receptor-interacting protein kinase 1 gene polymorphisms may correlate with prognosis in patients with diffuse large B cell lymphoma treated with R-CHOP. Cancer Chemother Pharmacol. 2010 Feb; 65(3):571-7. PMID: 19629486.
      View in: PubMed
    102. Moon JH, Sohn SK, Lee MH, Jang JH, Kim K, Jung CW, Kim DH. BCL2 gene polymorphism could predict the treatment outcomes in acute myeloid leukemia patients. Leuk Res. 2010 Feb; 34(2):166-72. PMID: 19520430.
      View in: PubMed
    103. Kim JG, Sohn SK, Chae YS, Moon JH, Kim SN, Kang BW, Kim GC, Lee MH, Jeon SW, Chung HY, Yu W. No association of the NFKB1 insertion/deletion promoter polymorphism with survival in patients with gastric cancer. Jpn J Clin Oncol. 2009 Aug; 39(8):497-501. PMID: 19509001.
      View in: PubMed
    104. Lee SJ, Ahn BM, Kim JG, Sohn SK, Chae YS, Moon JH, Lee EB, Kim JC, Park IK, Jeon SW. Definitive chemoradiotherapy with capecitabine and cisplatin in patients with esophageal cancer: a pilot study. J Korean Med Sci. 2009 Feb; 24(1):120-5. PMID: 19270824; PMCID: PMC2650982.
    105. Kim JG, Chae YS, Sohn SK, Moon JH, Ryoo HM, Bae SH, Kum Y, Jeon SW, Lim KH, Kang BM, Park IJ, Choi GS, Jun SH. Prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) 8473T>C polymorphism associated with prognosis for patients with colorectal cancer treated with capecitabine and oxaliplatin. Cancer Chemother Pharmacol. 2009 Oct; 64(5):953-60. PMID: 19219602.
      View in: PubMed
    106. Kim SN, Moon JH, Kim JG, Chae YS, Cho YY, Lee SJ, Kim YJ, Lee YJ, Suh JS, Lee KS, Sohn SK. Mobilization effects of G-CSF, GM-CSF, and darbepoetin-alpha for allogeneic peripheral blood stem cell transplantation. J Clin Apher. 2009; 24(5):173-9. PMID: 19753648.
      View in: PubMed
    107. Chae YS, Sohn SK, Kim JG, Cho YY, Moon JH, Yang DH, Lee JJ, Kim YK, Kim HJ, Shin HJ, Chung JS, Cho GJ. Impact of alemtuzumab as conditioning regimen component on transplantation outcomes in case of CMV-seropositive recipients and donors. Am J Hematol. 2008 Aug; 83(8):649-53. PMID: 18528826.
      View in: PubMed
    108. Chae YS, Kim JG, Sohn SK, Cho YY, Ahn BM, Moon JH, Jeon SW, Park JY, Lee IT, Choi GS, Jun SH. Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer. J Korean Med Sci. 2008 Jun; 23(3):421-7. PMID: 18583877; PMCID: PMC2526538.
    109. Kim JG, Chae YS, Sohn SK, Cho YY, Moon JH, Park JY, Jeon SW, Lee IT, Choi GS, Jun SH. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin Cancer Res. 2008 Jan 01; 14(1):62-6. PMID: 18172253.
      View in: PubMed
    110. Sohn SK, Moon JH, Cho YY, Chae YS, Kim JG, Lee KS, Hong SP, Kim SO. Efficacy of dose escalation of imatinib mesylate in patients with cytogenetic or hematologic resistance. Leuk Lymphoma. 2007 Aug; 48(8):1659-61. PMID: 17701605.
      View in: PubMed
    111. Chae YS, Kim JG, Sohn SK, Cho YY, Moon JH, Bae HI, Park JY, Lee MH, Lee HC, Chung HY, Yu W. Investigation of vascular endothelial growth factor gene polymorphisms and its association with clinicopathologic characteristics in gastric cancer. Oncology. 2006; 71(3-4):266-72. PMID: 17671399.
      View in: PubMed
    112. Moon JH, Kim JG, Sohn SK, Baek JH, Cho YY, Chae YS, Ahn BM, Kim SN, Lee SJ, Lee IT, Choi GS, Jun SH. Outpatient-basis chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin as first-line treatment for patients with metastatic or recurrent colorectal cancer. J Korean Med Sci. 2007 Jun; 22(3):400-4. PMID: 17596644; PMCID: PMC2693628.
    113. Moon JH, Park SH, Oh KC, Jung JO, Shin WG, Kim JP, Kim KO, Park CH, Hahn T, Yoo KS, Kim JH, Kim DJ, Lee MS, Park CK, Jun SY. [Association of hepatic iron deposition and serum iron indices with hepatic inflammation and fibrosis stage in nonalcoholic fatty liver disease]. Korean J Gastroenterol. 2006 Jun; 47(6):432-9. PMID: 16809950.
      View in: PubMed
    114. Yoo BK, Yoo KS, Park CS, Lee JW, Yoo JY, Moon JH, Jung JO, Kim JP, Kim KO, Park CH, Hahn TH, Park SH, Kim JH, Min SK, Yang DH, Park CK. [A case of retroperitoneal schwannoma of the vagus nerve]. Korean J Gastroenterol. 2005 Oct; 46(4):302-5. PMID: 16247275.
      View in: PubMed
    115. Sung WJ, Kim DH, Sohn SK, Kim JG, Baek JH, Jeon SB, Moon JH, Ahn BM, Lee KB. Phase II trial of amsacrine plus intermediate-dose Ara-C (IDAC) with or without etoposide as salvage therapy for refractory or relapsed acute leukemia. Jpn J Clin Oncol. 2005 Oct; 35(10):612-6. PMID: 16172175.
      View in: PubMed
    116. Lee SS, Moon JH, Ha JW, Lee YK, Ahn JS, Zang DY, Kim HJ. A case of transition of polycythemia vera to chronic neutrophilic leukemia. Korean J Intern Med. 2004 Dec; 19(4):285-8. PMID: 15683121; PMCID: PMC4531574.
    Moon's networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description